Eli Lilly
FDA Approves Lartruvo for Advanced Soft Tissue Sarcoma
Lartruvo is the first FDA-approved front-line therapy for soft tissue sarcoma in four decades.
OCTOBER 20, 2016
FDA Approves Taltz To Treat Psoriasis
Psoriasis affects approximately 7.5 million Americans, approximately 20% of whom have moderate to severe plaque ...
MARCH 23, 2016
Load more